The Centre for Cell and Vector Production: a look inside

CCVP video image

CCRM, in partnership with University Health Network, has built a Good Manufacturing Practices facility to produce cells and viral vectors for Phase I and II clinical trials. Now welcoming clients, the Centre for Cell and Vector Production (CCVP) is a 20,000 sq. ft. space featuring ISO Class 7/Grade B cell and viral vector clean rooms – 10 in total. Watch our video for a view into this leading-edge facility and hear from Susan Marlin, of Clinical Trials Ontario, along with others, on why CCVP is so important for Toronto and Canada. Working with academics, cell therapy and gene therapy developers, CCRM is continuing to drive the industry closer to delivering on the promise of regenerative medicine as a possible cure for many devastating diseases and conditions.

The CCVP video, produced by Big Red Oak, has won the 2019 Videographer Award of Excellence (the highest level). The Videographer Awards “recognize works that are written, produced, shot and/or edited in an exceptional manner.” The awards are administered and judged by the international Association of Marketing and Communication Professionals as part of the dotCOMM Awards.  

 

Bringing Immunotherapies to Ontario

Bringing Immunotherapies to Ontario Panel

Using genetic engineering, immunotherapies mobilize the body’s own cells against cancer. This revolutionary therapy has demonstrated remarkable curative potential, but comes with a big price tag and many complex technical challenges. Health-care providers, governments and industry are working on solutions that will make this therapy widely available. With the first immunotherapies having won regulatory approval in the United States, we are slowly making progress. What does this mean for Canada? What are the key challenges we need to address to bring immunotherapy to patients here at home?

The discussion included:
– Michael May, PhD, President & CEO, CCRM (Moderator) 
– Donna Wall, MD, Section Head – Blood and Marrow Transplant/Cell Therapy Program, Division of Haematology/Oncology, The Hospital for Sick Children
– Justin Shakespeare, Executive Director, Oncology Business Unit, Amgen 
– Patrick Bedford, Senior Manager, Clinical Translation and Regulatory Affairs, CCRM
– Aaron Dulgar-Tulloch, PhD, Director of BridGE, GE Healthcare Cell Therapy

This event took place during Toronto Health Innovation Week 2018, on April 11, 2018.

Fulfilling the Promise of Much-Needed Cures

Research2Reality video thumbnail

Regenerative medicine could revolutionize healthcare by providing actual cures to so many diseases where we are currently only treating symptoms. But the field is so new that there are exceptional hurdles to getting great ideas from the bench to the clinic.

Michael May is the president and CEO of CCRM, and he is bringing together the players who are needed to translate stem cell discoveries into commercial products.

This video was created by Research2Reality (R2R), which is a groundbreaking initiative that shines a spotlight on world-class scientists engaged in innovative and leading edge research in Canada. R2R’s video series celebrates the success of researchers who are establishing the new frontiers of science and to share the impact of their discoveries with the public.

Canada eyes leading role in regenerative medicine

Scientists tour CCRM's laboratory facility

Getting a promising new product to market can be a challenge, and this is especially true in medicine. From the earliest stages of development through to clinical trials, proving that new therapeutics work can take a lot of time and investment. CCRM bridges the gap between the lab and the clinic, helping accelerate stem cell therapies to the market.

This video was created by Research2Reality (R2R), which is a groundbreaking initiative that shines a spotlight on world-class scientists engaged in innovative and leading edge research in Canada. R2R’s video series celebrates the success of researchers who are establishing the new frontiers of science and to share the impact of their discoveries with the public.

All other pages contact

For more information, please contact us.
Font Resize
Enable Contrast